Multicenter Experience With a Novel Real‐Time 3‐Dimensional Intracardiac Echocardiography Catheter to Guide Interventional Cardiac Procedures
Open Access
- 13 March 2025
- journal article
- imaging
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (6) , e037019
Abstract
Background: Recent technologies enable real‐time 3‐dimensional intracardiac echocardiography (ICE) with the advantages of 2‐dimensional ICE and imaging capabilities of transesophageal echocardiography. The purpose of this study is to evaluate the real‐world, multicenter safety and performance of a novel 3‐dimensional ICE system in a variety of cardiac interventions used in standard clinical practice. Methods: This prospective, multicenter, observational, single‐arm study enrolled patients who were scheduled for an invasive cardiac procedure involving guidance with ICE and followed until discharge or ≤48 hours postprocedure. Intracardiac imaging was performed with the 3‐dimensional ICE catheter, VeriSight Pro (Philips Inc.). Fluoroscopy was used in all cases and transesophageal echocardiography was used in some cases. The primary safety end point was device‐related adverse events. The primary efficacy end point included technical success, imaging success, and clinical success. Results: Between October 2021 and November 2022, 155 patients were enrolled and screened. Percutaneous interventions performed included atrial septal defect/patent foramen ovale closures, left atrial appendage occlusion, catheter ablations, and valve procedures. No adverse events were related to the device or procedure. The technical, imaging, and clinical success rates were 98.7% (95% CI, 95.4%–99.8%), 96.1% (95% CI, 91.8%–98.6%), 94.8% (95% CI, 91.8%–98.6%), respectively. Overall, the VeriSight Pro ICE image quality was assessed to be “acceptable” or greater in relation to reference image modality among 96.2% (149 of 155) of procedures. Conclusions: VeriSight ICE imaging is safe and effective in the guidance of a wide variety of percutaneous cardiovascular procedures and has provided successful and high‐quality imaging of cardiac structures.Keywords
This publication has 48 references indexed in Scilit:
- Intracardiac echocardiography for guidance of transcatheter left atrial appendage occlusion: An expert consensus documentCatheterization and Cardiovascular Interventions, 2021
- Intracardiac Echocardiography to Guide Non-fluoroscopic Electrophysiology ProceduresCardiac Electrophysiology Clinics, 2021
- Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or ReplacementJournal of the American Society of Echocardiography, 2019
- Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchmanCatheterization and Cardiovascular Interventions, 2016
- Intracardiac echocardiography‐guided transcatheter aortic valve replacementCatheterization and Cardiovascular Interventions, 2014
- Intracardiac echocardiography in complex cardiac catheter ablation proceduresJournal of Interventional Cardiac Electrophysiology, 2010
- Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communicationsEuropean Heart Journal - Cardiovascular Imaging, 2005
- Initial clinical experience with intracardiac echocardiography in guiding balloon mitral valvuloplasty: Technique, safety, utility, and limitationsCatheterization and Cardiovascular Interventions, 2004
- Comparison of costs of intracardiac echocardiography and transesophageal echocardiography in monitoring percutaneous device closure of atrial septal defect in children and adultsThe American Journal of Cardiology, 2004
- Comparison of intracardiac echocardiography versus transesophageal echocardiography guidance for percutaneous transcatheter closure of atrial septal defectThe American Journal of Cardiology, 2004